Directly observed antiretroviral therapy eliminates adverse effects of active drug use on adherence

Shadi Nahvi, Alain H. Litwin, Moonseong Heo, Karina M. Berg, Xuan Li, Julia H. Arnsten

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: The impact of adherence enhancing interventions on the relationship between active drug use and adherence is largely unknown. Methods: We conducted a 24-week randomized controlled trial of antiretroviral directly observed therapy (DOT) vs. treatment as usual (TAU) among HIV-infected methadone patients. Our outcome measure was pill count antiretroviral adherence, and our major independent variables were treatment arm (DOT vs. TAU) and active drug use (opiates, cocaine, or both opiates and cocaine). We defined any drug use as ≥1 positive urine toxicology result, and frequent drug use as ≥50% tested urines positive. We used mixed-effects linear models to evaluate associations between adherence and drug use, and included a treatment arm-by-drug use interaction term to evaluate whether DOT moderates associations between drug use and adherence. Results: 39 participants were randomized to DOT and 38 to TAU. We observed significant associations between adherence and active drug use, but these were limited to TAU participants. Adherence was worse in TAU participants with any opiate use than in TAU participants without (63% vs. 75%, p< 0.01); and worse among those with any polysubstance (both opiate and cocaine) use than without (60% vs. 73%, p = 0.01). We also observed significant decreases in adherence among TAU participants with frequent opiate or frequent polysubstance use, compared to no drug use. Among DOT participants, active drug use was not associated with worse adherence. Conclusions: Active opiate or polysubstance use decreases antiretroviral adherence, but the negative impact of drug use on adherence is eliminated by antiretroviral DOT.

Original languageEnglish (US)
Pages (from-to)174-180
Number of pages7
JournalDrug and Alcohol Dependence
Volume120
Issue number1-3
DOIs
StatePublished - Jan 1 2012

Fingerprint

Directly Observed Therapy
Opiate Alkaloids
Pharmaceutical Preparations
Therapeutics
Cocaine
Urine
Methadone
Drug Interactions
Toxicology
Linear Models
Randomized Controlled Trials

Keywords

  • Directly observed therapy
  • HIV
  • Medication adherence
  • Methadone
  • Randomized trial
  • Substance use

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Toxicology
  • Pharmacology
  • Pharmacology (medical)

Cite this

Directly observed antiretroviral therapy eliminates adverse effects of active drug use on adherence. / Nahvi, Shadi; Litwin, Alain H.; Heo, Moonseong; Berg, Karina M.; Li, Xuan; Arnsten, Julia H.

In: Drug and Alcohol Dependence, Vol. 120, No. 1-3, 01.01.2012, p. 174-180.

Research output: Contribution to journalArticle

Nahvi, Shadi ; Litwin, Alain H. ; Heo, Moonseong ; Berg, Karina M. ; Li, Xuan ; Arnsten, Julia H. / Directly observed antiretroviral therapy eliminates adverse effects of active drug use on adherence. In: Drug and Alcohol Dependence. 2012 ; Vol. 120, No. 1-3. pp. 174-180.
@article{c36fe4de3ba04de1a42e019a897a48eb,
title = "Directly observed antiretroviral therapy eliminates adverse effects of active drug use on adherence",
abstract = "Background: The impact of adherence enhancing interventions on the relationship between active drug use and adherence is largely unknown. Methods: We conducted a 24-week randomized controlled trial of antiretroviral directly observed therapy (DOT) vs. treatment as usual (TAU) among HIV-infected methadone patients. Our outcome measure was pill count antiretroviral adherence, and our major independent variables were treatment arm (DOT vs. TAU) and active drug use (opiates, cocaine, or both opiates and cocaine). We defined any drug use as ≥1 positive urine toxicology result, and frequent drug use as ≥50{\%} tested urines positive. We used mixed-effects linear models to evaluate associations between adherence and drug use, and included a treatment arm-by-drug use interaction term to evaluate whether DOT moderates associations between drug use and adherence. Results: 39 participants were randomized to DOT and 38 to TAU. We observed significant associations between adherence and active drug use, but these were limited to TAU participants. Adherence was worse in TAU participants with any opiate use than in TAU participants without (63{\%} vs. 75{\%}, p< 0.01); and worse among those with any polysubstance (both opiate and cocaine) use than without (60{\%} vs. 73{\%}, p = 0.01). We also observed significant decreases in adherence among TAU participants with frequent opiate or frequent polysubstance use, compared to no drug use. Among DOT participants, active drug use was not associated with worse adherence. Conclusions: Active opiate or polysubstance use decreases antiretroviral adherence, but the negative impact of drug use on adherence is eliminated by antiretroviral DOT.",
keywords = "Directly observed therapy, HIV, Medication adherence, Methadone, Randomized trial, Substance use",
author = "Shadi Nahvi and Litwin, {Alain H.} and Moonseong Heo and Berg, {Karina M.} and Xuan Li and Arnsten, {Julia H.}",
year = "2012",
month = "1",
day = "1",
doi = "10.1016/j.drugalcdep.2011.07.025",
language = "English (US)",
volume = "120",
pages = "174--180",
journal = "Drug and Alcohol Dependence",
issn = "0376-8716",
publisher = "Elsevier Ireland Ltd",
number = "1-3",

}

TY - JOUR

T1 - Directly observed antiretroviral therapy eliminates adverse effects of active drug use on adherence

AU - Nahvi, Shadi

AU - Litwin, Alain H.

AU - Heo, Moonseong

AU - Berg, Karina M.

AU - Li, Xuan

AU - Arnsten, Julia H.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Background: The impact of adherence enhancing interventions on the relationship between active drug use and adherence is largely unknown. Methods: We conducted a 24-week randomized controlled trial of antiretroviral directly observed therapy (DOT) vs. treatment as usual (TAU) among HIV-infected methadone patients. Our outcome measure was pill count antiretroviral adherence, and our major independent variables were treatment arm (DOT vs. TAU) and active drug use (opiates, cocaine, or both opiates and cocaine). We defined any drug use as ≥1 positive urine toxicology result, and frequent drug use as ≥50% tested urines positive. We used mixed-effects linear models to evaluate associations between adherence and drug use, and included a treatment arm-by-drug use interaction term to evaluate whether DOT moderates associations between drug use and adherence. Results: 39 participants were randomized to DOT and 38 to TAU. We observed significant associations between adherence and active drug use, but these were limited to TAU participants. Adherence was worse in TAU participants with any opiate use than in TAU participants without (63% vs. 75%, p< 0.01); and worse among those with any polysubstance (both opiate and cocaine) use than without (60% vs. 73%, p = 0.01). We also observed significant decreases in adherence among TAU participants with frequent opiate or frequent polysubstance use, compared to no drug use. Among DOT participants, active drug use was not associated with worse adherence. Conclusions: Active opiate or polysubstance use decreases antiretroviral adherence, but the negative impact of drug use on adherence is eliminated by antiretroviral DOT.

AB - Background: The impact of adherence enhancing interventions on the relationship between active drug use and adherence is largely unknown. Methods: We conducted a 24-week randomized controlled trial of antiretroviral directly observed therapy (DOT) vs. treatment as usual (TAU) among HIV-infected methadone patients. Our outcome measure was pill count antiretroviral adherence, and our major independent variables were treatment arm (DOT vs. TAU) and active drug use (opiates, cocaine, or both opiates and cocaine). We defined any drug use as ≥1 positive urine toxicology result, and frequent drug use as ≥50% tested urines positive. We used mixed-effects linear models to evaluate associations between adherence and drug use, and included a treatment arm-by-drug use interaction term to evaluate whether DOT moderates associations between drug use and adherence. Results: 39 participants were randomized to DOT and 38 to TAU. We observed significant associations between adherence and active drug use, but these were limited to TAU participants. Adherence was worse in TAU participants with any opiate use than in TAU participants without (63% vs. 75%, p< 0.01); and worse among those with any polysubstance (both opiate and cocaine) use than without (60% vs. 73%, p = 0.01). We also observed significant decreases in adherence among TAU participants with frequent opiate or frequent polysubstance use, compared to no drug use. Among DOT participants, active drug use was not associated with worse adherence. Conclusions: Active opiate or polysubstance use decreases antiretroviral adherence, but the negative impact of drug use on adherence is eliminated by antiretroviral DOT.

KW - Directly observed therapy

KW - HIV

KW - Medication adherence

KW - Methadone

KW - Randomized trial

KW - Substance use

UR - http://www.scopus.com/inward/record.url?scp=84155164318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84155164318&partnerID=8YFLogxK

U2 - 10.1016/j.drugalcdep.2011.07.025

DO - 10.1016/j.drugalcdep.2011.07.025

M3 - Article

C2 - 21885212

AN - SCOPUS:84155164318

VL - 120

SP - 174

EP - 180

JO - Drug and Alcohol Dependence

JF - Drug and Alcohol Dependence

SN - 0376-8716

IS - 1-3

ER -